Evidence map›Paper›PMID 39323442›Full record

ArticleWorld journal of virology2024

Recurrent stroke admissions with

Rupak Desai, Sai Priyanka Mellacheruvu, Sai Anusha Akella, Adil Sarvar Mohammed, Mushfequa Hussain, Abdul Aziz Mohammed, Pakhal Saketha, Praveena Sunkara, Jyotsna Gummadi, Paritharsh Ghantasala

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rupak DesaiOutcomes Research, Independent Researcher, Atlanta, GA 30033, United States.
Sai Priyanka MellacheruvuDepartment of Public Health, University of Massachusetts, Lowell, MA 01854, United States.
Sai Anusha AkellaDepartment of Internal Medicine, One Brooklyn Health- Interfaith Medical Center, Brooklyn, NY 11213, United States.
Adil Sarvar MohammedDepartment of Internal Medicine, Central Michigan University College of Medicine, Saginaw, MI 48602, United States.
Mushfequa HussainDepartment of Internal Medicine, Kamineni Institute of Medical Sciences, Narketpally 508254, India.
Abdul Aziz MohammedDepartment of Internal Medicine, Kamineni Institute of Medical Sciences, Narketpally 508254, India. s.aadil19@gmail.com.
Pakhal SakethaDepartment of Internal Medicine, Bhaskar Medical College, Moinabad 500075, Hyderabad, India.
Praveena SunkaraDepartment of Internal Medicine, MedStar Medical Group, Charlotte Hall, MD 20622, United States.
Jyotsna GummadiDepartment of Medicine, Medstar Franklin Square Medical Center, Baltimore, MD 21237, United States.
Paritharsh GhantasalaDepartment of Internal Medicine, Central Michigan University College of Medicine, Saginaw, MI 48602, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) has been shown to increase the risk of stroke. However, the prevalence and risk of recurrent stroke in COVID-19 patients with prior stroke/transient ischemic attack (TIA), as well as its impact on mortality, are not established.

aimTo evaluate the impact of COVID-19 on in-hospital mortality, length of stay, and healthcare costs in patients with recurrent strokes.

methodsWe identified admissions of recurrent stroke (current acute ischemic stroke admissions with at least one prior TIA or stroke) in patients with and without COVID-19 using ICD-10-CM codes using the National Inpatient Sample (2020). We analyzed the impact of COVID-19 on mortality following recurrent stroke admissions by subgroups.

resultsOf 97455 admissions with recurrent stroke, 2140 (2.2%) belonged to the COVID-19-positive group. The COVID-19-positive group had a higher prevalence of diabetes and chronic kidney disease

conclusionThe study highlights the increased risk of all-cause in-hospital mortality in recurrent stroke patients with COVID-19, with a more pronounced increase in middle-aged patients, males, Hispanics, or Asians.

Indexed as

Acute ischemic strokeComorbiditiesCOVID-19HospitalizationMortalityRecurrent strokeSARS-CoV-2

Identifiers

PMID39323442
PMCPMC11401001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.